Granules Pharmaceuticals, Inc gets 2 observations for Chantilly, Virginia facility

US FDA has completed inspection of the facility of Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of the Company located in Chantilly, Virginia, USA on 25th June 2021 with two (2) minor observations. This is a pre-approval inspection for the products filed from this facility. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time.

Shares of GRANULES INDIA LTD. was last trading in BSE at Rs.313.95 as compared to the previous close of Rs. 310.75. The total number of shares traded during the day was 53435 in over 1308 trades.

The stock hit an intraday high of Rs. 315.3 and intraday low of 310.65. The net turnover during the day was Rs. 16715603.

Source : Equity Bulls

Keywords